Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current pharmaceutical design

• Publication date

  2008-03-31

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.2174/138161208784139729PMID 18473846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.

  2007cited by this paper
• Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy

  2007cited by this paper
• Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

  2007cited by this paper
• Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.

  2007cited by this paper
• Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.

  2007cited by this paper
• Pigment epithelium-derived factor (PEDF) prevents advanced glycation end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its anti-oxidative properties.

  2007cited by this paper
• Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders.

  2007cited by this paper
• Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.

  2007cited by this paper
• Pigment-Epithelium-Derived Factor Suppresses Expression of Receptor for Advanced Glycation End Products in the Eye of Diabetic Rats

  2007cited by this paper
• Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

  2006cited by this paper
• Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.

  2006cited by this paper
• Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression*

  2006cited by this paper
• Endothelial mechanotransduction, nitric oxide and vascular inflammation

  2006cited by this paper
• Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes.

  2006cited by this paper
• From the design to the clinical application of thromboxane modulators.

  2006cited by this paper
• Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes.

  2006cited by this paper
• TAGE (toxic AGEs) theory in diabetic complications.

  2006cited by this paper
• Pericytes and the Pathogenesis of Diabetic Retinopathy

  2005cited by this paper
• Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.

  2005cited by this paper
• Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy

  2005cited by this paper
• Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

  2005cited by this paper
• Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.

  2005cited by this paper
• Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.

  2005cited by this paper
• Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.

  2005cited by this paper
• Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.

  2005cited by this paper
• Angiotensin II augments advanced glycation end product‐induced pericyte apoptosis through RAGE overexpression

  2005cited by this paper
• Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.

  2005cited by this paper
• The RAGE axis in early diabetic retinopathy.

  2005cited by this paper
• Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.

  2004cited by this paper
• Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic Psammomys obesus

  2004cited by this paper
• The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.

  2003cited by this paper
• Angiotensin II stimulates platelet-derived growth factor-B gene expression in cultured retinal pericytes through intracellular reactive oxygen species generation.

  2003cited by this paper
• Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

  2003cited by this paper
• The role of advanced glycation end products in retinal microvascular leukostasis.

  2003cited by this paper
• VEGF164 is proinflammatory in the diabetic retina.

  2003cited by this paper
• Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation

  2003cited by this paper
• Angiotensin II-type 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation.

  2003cited by this paper
• The role of advanced glycation in the pathogenesis of diabetic retinopathy.

  2003cited by this paper
• Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.

  2003cited by this paper
• Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.

  2002cited by this paper
• Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.

  2002cited by this paper
• Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

  2002cited by this paper
• The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

  2002cited by this paper
• Diabetes and advanced glycation endproducts

  2002cited by this paper
• Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus.

  2002cited by this paper
• Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction.

  2002cited by this paper
• Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.

  2002cited by this paper
• Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.

  2002cited by this paper
• Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.

  2002cited by this paper
• Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

  2002cited by this paper
• Beraprost Sodium, a Prostaglandin I2 Analogue, Protects Against Advanced Glycation End Products-induced Injury in Cultured Retinal Pericytes

  2002cited by this paper
• Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.

  2002cited by this paper
• The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats

  2001cited by this paper
• Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.

  2001cited by this paper
• Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

  2001cited by this paper
• Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy

  2001cited by this paper
• Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

  2000cited by this paper
• Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

  2000cited by this paper
• Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.

  1999cited by this paper
• Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor.

  1999cited by this paper
• VEGF increases retinal vascular ICAM-1 expression in vivo.

  1999cited by this paper
• Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells.

  1998cited by this paper
• A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

  1998cited by this paper
• Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

  1998cited by this paper
• Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells

  1998cited by this paper
• AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

  1998cited by this paper
• Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic Retinopathy

  1998cited by this paper
• Increased aggregation of human platelets produced by advanced glycation end products in vitro.

  1998cited by this paper
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997cited by this paper
• Advanced Glycation End Products-driven Angiogenesis in Vitro

  1997cited by this paper
• Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.

  1997cited by this paper
• Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin‐producing ability of endothelial cells through interactions with their receptors

  1996cited by this paper
• Blood vessel formation: what is its molecular basis?

  1996cited by this paper
• Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy.

  1995cited by this paper
• Tumour necrosis factor alpha‐induced oxidative burst in neutrophils adherent to fibronectin: effects of cyclic AMP‐elevating agents

  1995cited by this paper
• Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.

  1995cited by this paper
• Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*)

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes.

  1993cited by this paper
• Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells.

  1993cited by this paper
• On the pathogenesis of diabetic retinopathy. A 1990 update.

  1991cited by this paper
• Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

  1991cited by this paper
• Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo.

  1991cited by this paper
• Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors.

  1991cited by this paper
• An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.

  1989cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Retinal vascular patterns. IV. Diabetic retinopathy.

  1961cited by this paper

• Complicaciones Microvasculares en Pacientes con Diabetes de Larga Evolución: Análisis Clínico y Proyecciones Terapéuticas

  2025cites this paper
• Quantitative Analysis of Changes in Hard Exudates in Diabetic Retinopathy Patients Taking Oral Supplements

  2025cites this paper
• Modulation of Oxidative Stress in Diabetic Retinopathy: Therapeutic Role of Natural Polyphenols

  2025cites this paper
• Effect of advanced glycation end-products in a wide range of medical problems including COVID-19.

  2024cites this paper
• Association between renal function and the Treatment of Diabetic Macular Edema in Long-Term Cohort Study

  2024cites this paper
• Biochemical Changes in Anterior Chamber of the Eye in Diabetic Patients—A Review

  2024cites this paper
• Discovering potential pathways between type 2 diabetes mellitus and diabetic retinopathy: A big data analysis of the South Korean National Sample Cohort

  2023cites this paper
• Dendropanoxide Attenuates High Glucose-induced Oxidative Damage in NRK-52E Cells via AKT/mTOR Signaling Pathway

  2023cites this paper
• Proteins in human body fluids contain in vivo antigen analog of the melibiose-derived glycation product: MAGE

  2022cites this paper
• Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists.

  2021cites this paper
• Type 1 Diabetes and Associated Cardiovascular Damage: Contribution of Extracellular Vesicles in Tissue Crosstalk

  2021cites this paper
• Fufang Xueshuantong alleviates diabetic retinopathy by activating the PPAR signalling pathway and complement and coagulation cascades.

  2020cites this paper
• The protective effects of bexarotene against advanced glycation end-product (AGE)-induced degradation of articular extracellular matrix (ECM)

  2020cites this paper
• Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-κB pathway in ApoE−/− mice

  2020cites this paper
• The inefficacy of donepezil on glycated-AChE inhibition: Binding affinity, complex stability and mechanism.

  2020cites this paper
• Tandem mass tag-based proteomic analysis reveals cathepsin-mediated anti-autophagic and pro-apoptotic effects under proliferative diabetic retinopathy

  2020cites this paper
• Phytochemical Analysis, In vitro Antioxidant Activity and Inhibition of Key Diabetic Enzymes by Selected Nigerian Medicinal Plants with Antidiabetic Potential

  2019cites this paper
• Protective effects of astaxanthin against diabetic retinal vessels and pro-inflammatory cytokine synthesis

  2019cites this paper
• Real-life experience of ranibizumab for diabetic macular edema in Taiwan

  2018cites this paper
• Immunochemical studies on native and glycated LDL - An approach to uncover the structural perturbations.

  2018cites this paper
• Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials.

  2018cites this paper
• Relationship between Systemic Vascular Characteristics and Retinal Nerve Fiber Layer Loss in Patients with Type 2 Diabetes

  2018cites this paper
• Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema

  2017cites this paper
• Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy

  2017cites this paper
• Role of moesin, Src, and ROS in advanced glycation end product‐induced vascular endothelial dysfunction

  2017cites this paper
• Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway

  2016cites this paper
• Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetes

  2016cites this paper
• Adequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians

  2016cites this paper
• Accelerated degradation of collagen membranes in diabetic rats is associated with increased infiltration of macrophages and blood vessels

  2016cites this paper
• PHYTOCHEMISTRY, ANTIOXIDATIVE ACTIVITY AND INHIBITION OF KEY ENZYMES LINKED TO TYPE 2 DIABETES BY VARIOUS PARTS OF AFRAMOMUM MELEGUETA IN VITRO.

  2016cites this paper
• Mechanisms of diabetic nephropathy mediated by AGEs and effects of metformin intervention

  2016cites this paper
• Glycemic Index and Diabetes Mellitus: Evidence on Prevention and Management and Implications on Insulin Resistance

  2016cites this paper
• Role of Lycium Barbarum Extracts in Retinal Diseases

  2015cites this paper
• Free Amino Acids Glycine and Glutamic Acid Inhibit Angiogenesis Induced by AGE in Bovine Retinal Endothelial Cells

  2015cites this paper
• Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients

  2015cites this paper
• Ghrelin protects human umbilical vein endothelial cells against advanced glycation end products-induced apoptosis via NO/cGMP signaling.

  2015cites this paper
• Inflammation and Oxidative Stress in Retinal Diseases: The Role of Intracellular Signaling in the Retinal Pigment Epithelium

  2015influential citation
• Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia

  2015cites this paper
• Pathogenesis of diabetic retinopathy: Biochemical aspects and therapeutic approaches

  2015cites this paper
• Diabetic Macular Edema: Options for Adjunct Therapy

  2015cites this paper
• Inhibitory effects and actions of pentacyclic triterpenes upon glycation

  2015cites this paper
• Retinopathy in non diabetics, diabetic retinopathy and oxidative stress: a new phenotype in Central Africa?

  2014cites this paper
• Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy

  2014cites this paper
• Neuropeptides, trophic factors, and other substances providing morphofunctional and metabolic protection in experimental models of diabetic retinopathy.

  2014cites this paper
• Retinopathy in non diabetics , diabetic retinopathy and oxidative stress : a new phenotype in Central Africa ?

  2014cites this paper
• Modified Si-Miao-San ameliorates pancreatic B cell dysfunction by inhibition of reactive oxygen species-associated inflammation through AMP-kinase activation.

  2014cites this paper
• Preparation of Preproinsulin Gene Construct Containing the Metallothionein2A (pBINDMTChIns) and Its Expression in NIH3T3 Cell Line and Muscle Tissue of Alloxan Diabetic Rabbits

  2014cites this paper
• Vascular reactive oxygen species biology - Insights from transgenic and knockout mouse models

  2014cites this paper
• Inhibition of protein glycation by essential oils of branchlets and fruits of Juniperus communis subsp. hemisphaerica

  2014cites this paper
• Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms and Circulating RAGE Levels with Diabetic Retinopathy in the Chinese Population

  2013influential citation
• Increased Bacterial Adherence and Decreased Bacterial Clearance in Urinary Tract Infections with Diabetes Mellitus

  2013cites this paper
• Neuroretinal activation in diabetes mellitus

  2013cites this paper
• Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus

  2013cites this paper
• Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization

  2012cites this paper
• Anti-glycative potential of triterpenes: A mini-review

  2012cites this paper
• Glycated Albumin and Pathological Shear Stress Alters Endothelial Cell Thrombogenic Potential, Pro-Inflammatory State and Cytoskeletal Dynamics

  2012cites this paper
• Serum prolidase activity and oxidative status in patients with diabetic neuropathy

  2012cites this paper
• Oxidative Stress in Preretinopathic Diabetes Subjects and Antioxidants

  2012cites this paper
• Circulating biomarkers of diabetic retinopathy: a systematic review and meta-analysis

  2012cites this paper
• Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1

  2012cites this paper
• Metabolic memory: mechanisms and implications for diabetic retinopathy.

  2012cites this paper
• Effects of N1-methylnicotinamide on oxidative and glycooxidative stress markers in rats with streptozotocin-induced diabetes mellitus

  2012cites this paper
• Vascular memory: can we broaden the concept of the metabolic memory?

  2012cites this paper
• Role of Redox Metals, Oxidative Protein Products and Antioxidant Potentials of Thiols in Diabetic Retinopathy

  2012cites this paper
• Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium

  2012cites this paper
• Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms with Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis

  2012cites this paper
• Antiglycation and antioxidation properties of Juglans regia and Calendula officinalis: possible role in reducing diabetic complications and slowing down ageing.

  2012cites this paper
• Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men.

  2011cites this paper
• The proglycation effect of caffeic acid leads to the elevation of oxidative stress and inflammation in monocytes, macrophages and vascular endothelial cells.

  2011cites this paper
• Decreased contrast sensitivity in children and adolescents with type 1 diabetes mellitus.

  2011cites this paper
• Relationship between antioxidant and antiglycation ability of saponins, polyphenols, and polysaccharides in Chinese herbal medicines used to treat diabetes

  2011cites this paper
• Sigma receptor 1 modulates endoplasmic reticulum stress in retinal neurons.

  2011cites this paper
• Efficiency of trapping methylglyoxal by phenols and phenolic acids.

  2011cites this paper
• Role of Oxidative Stress and Targeted Antioxidant Therapies in Experimental Models of Diabetic Complications

  2011cites this paper
• Sweet and sour--oxidative and carbonyl stress in neurological disorders.

  2011cites this paper
• Systemic AAV-mediated gene therapy using Epo-R76E to protect retinal ganglion cells from optic nerve injury and disease

  2011cites this paper
• Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.

  2011cites this paper
• Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

  2011influential citation
• The Study of Glycative and Oxidative Stress in Type 1 Diabetes Patients in Relation to Circulating TGF-Beta1, VCAM-1 and Diabetic Vascular Complications

  2011cites this paper
• Increased Accumulation of Skin Advanced Glycation End Products Is Associated with Microvascular Complications in Type 1 Diabetes

  2011cites this paper
• Iron Overload in Diabetic Retinopathy: A Cause or a Consequence of Impaired Mechanisms?

  2010cites this paper
• RAGE: a multi-ligand receptor unveiling novel insights in health and disease.

  2010cites this paper
• Reduction of Inducible Nitric Oxide Synthase via Angiotensin Receptor Blocker Prevents the Oxidative Retinal Damage in Diabetic Hypertensive Rats

  2010cites this paper
• Comparison of Sour and Black Tea Consumption on the Serum Lipid Oxidizability in Diabetic Patients

  2010cites this paper
• Treatment of Proliferative Diabetic Retinopathy

  2010cites this paper
• Effect of Pyridoxamine on Diabetic Retinopathy and Diabetes-Induced Deterioration of Serum Lipids and Creatinine in Experimental Animals

  2010cites this paper
• Animal Models of Diabetic Retinopathy

  2010cites this paper
• Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation.

  2010cites this paper
• Animal Models for Retinal Diseases

  2010cites this paper
• Advanced glycation end product (AGE) modified proteins in tears of diabetic patients

  2010cites this paper
• Efficacy and Safety of Sulfonylurea Use in Permanent Neonatal Diabetes Due to KCNJ11 Gene Mutations: 34-Month Median Follow-Up

  2010influential citation
• ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.

  2010cites this paper
• Aging increases retinal vascular lesions characteristic of early diabetic retinopathy

  2010cites this paper
• Vieillissement vasculaire chez des patients athérosclérotiques: Sénescence prématurée des cellules endothéliales?

  2009cites this paper
• Antioxidant Status Modifications by Topical Administration of Dorzolamide in Primary Open-Angle Glaucoma

  2009cites this paper
• Fibrates and microvascular complications in diabetes--insight from the FIELD study.

  2009cites this paper
• Der Einfluß von Hydroxylradikalen auf den Tonus von Ziliararterien

  2009cites this paper
• High Glucose and Human Endothelial Cell Ageing

  2009cites this paper
• Stoffwechselgedächtnis, AGE-Bildung und diabetische Langzeitkomplikationen

  2009cites this paper
• Are the pleiotropic effects of telmisartan clinically relevant?

  2009cites this paper